Related Experiment Video
Updated: Nov 8, 2025
Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
Advanced Biomedical Applications of Reactive Oxygen Species-Based Nanomaterials in Lung Cancer
Nan Zhao1, Hua Xin1, Lening Zhang1
1Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun City, China.
Abstract:
Over the years, lung cancer remains the leading cause of cancer deaths in worldwide. In view of this, increasingly importance has been attached to the further optimization and improvement of its treatment. Reactive oxygen species (ROS) play a key role in regulating tumor development and anti-cancer treatment. Recently, the development of nanomaterials provides new platforms for ROS-based cancer treatment methods, which can help to reduce side effects and enhance anti-cancer effects. In recent years, a variety of lung cancer treatment models have been reported, such as chemodynamic therapy (CDT), photodynamic therapy (PDT), radiation therapy (RT) and controlled drug release (CDR). In this review, we are going to discuss the possible mechanism of action and current research status of ROS-based nanomaterials in the treatment of lung cancer in order to provide constructive ideas for relative research and expect this work could inspire the future development of novel lung cancer treatments.
Insights
Reactive oxygen species (ROS) are crucial in cancer treatment. ROS-based nanomaterials offer enhanced lung cancer therapies with reduced side effects, paving the way for innovative treatments.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Oncology
Background:
- Lung cancer is a leading global cause of cancer mortality.
- Optimizing lung cancer treatment remains a critical challenge.
- Reactive oxygen species (ROS) are integral to tumor progression and anti-cancer strategies.
Purpose of the Study:
- To review the mechanisms and current research on ROS-based nanomaterials for lung cancer treatment.
- To provide insights for future research and development in novel lung cancer therapies.
Main Methods:
- Literature review of ROS-based nanomaterials in lung cancer therapy.
- Discussion of therapeutic modalities including chemodynamic therapy (CDT), photodynamic therapy (PDT), radiation therapy (RT), and controlled drug release (CDR).
Main Results:
- Nanomaterials offer advanced platforms for ROS-mediated cancer treatment.
- These approaches aim to minimize side effects while maximizing anti-cancer efficacy.
- Various ROS-based therapeutic models are under investigation for lung cancer.
Conclusions:
- ROS-based nanomaterials represent a promising frontier in lung cancer treatment.
- Further research is needed to fully elucidate mechanisms and optimize clinical application.
- This review highlights the potential for novel nanomaterial-driven therapies to improve patient outcomes.
More Related Videos
Related Concept Videos
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...